Anti-CD52 Therapy in Experimental Autoimmune Encephalomyelitis

被引：0
|
作者：
Turner, Michael J.
Chretien, Nathalie
Havari, Evis
LaMorte, Michael
Roberts, Bruce
Kaplan, Johanne
Siders, William M.
机构：
来源：
ANNALS OF NEUROLOGY | 2012年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] Intrathecal administration of anti-CD20 in treatment of experimental autoimmune encephalomyelitis
    Lehmann-Horn, K.
    Radelfahr, F.
    Hemmer, B.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 137 - 137
  • [22] Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies
    Albitar, M
    Do, KA
    Johnson, MM
    Giles, FJ
    Jilani, I
    O'Brien, S
    Cortes, J
    Thomas, D
    Rassenti, LZ
    Kipps, TJ
    Kantarjian, HM
    Keating, M
    CANCER, 2004, 101 (05) : 999 - 1008
  • [23] Monoclonal anti-CD52 antibodies:: A potential mode of therapy for parvovirus B19 hepatitis
    Granot, E
    Miskin, H
    Aker, M
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2151 - 2153
  • [24] Gene Therapy in Experimental Autoimmune Encephalomyelitis
    Peter M. Mathisen
    Vincent K. Tuohy
    Journal of Clinical Immunology, 2000, 20 : 327 - 333
  • [25] Gene therapy in experimental autoimmune encephalomyelitis
    Mathisen, PM
    Tuohy, VK
    JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (05) : 327 - 333
  • [26] Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response
    Bierhansl, Laura
    Ruck, Tobias
    Pfeuffer, Steffen
    Gross, Catharina C.
    Wiendl, Heinz
    Meuth, Sven G.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2019, 1 (01):
  • [27] Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response
    Laura Bierhansl
    Tobias Ruck
    Steffen Pfeuffer
    Catharina C. Gross
    Heinz Wiendl
    Sven G. Meuth
    Neurological Research and Practice, 1
  • [28] Immune cell derived BDNF does not mediate neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse model
    Demir, Seray
    Pitarokoili, Kalliopi
    Linker, Ralf
    Gold, Ralf
    JOURNAL OF NEUROIMMUNOLOGY, 2019, 328 : 78 - 85
  • [29] Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity
    Holgate, Robert G. E.
    Weldon, Richard
    Jones, Timothy D.
    Baker, Matthew P.
    PLOS ONE, 2015, 10 (09):
  • [30] ANTIADHESION MOLECULE THERAPY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
    CANNELLA, B
    CROSS, AH
    RAINE, CS
    JOURNAL OF NEUROIMMUNOLOGY, 1993, 46 (1-2) : 43 - 56
12345